AXL and brain neoplasm: Single agent LY-2584702 strongly suppressed rpS6 phosphorylation, consistent with a recently published predictive analysis of brain penetrance (44), and single agent BMS-777607 also reduced phospho-rpS6, in line with previously described suppression of AXL phosphorylation in brain tumor xenografts (Fig. 1B; ref. 45).